spacing image
spacing image spacing image E-mail this page E-mail this page     Print this page Print this page
spacing image spacing image

Ramin Alemzadeh, MD

Diabetes and Endocrinology             

Ramin Alemzadeh, MDTitle(s): Program director, Diabetes, Children's Hospital of Wisconsin; professor, Medical College of Wisconsin.

Education: Medical degree, St. George's University, School of Medicine, Grenada, West Indies, 1982; internship, Surgery and OB/GYN, North Middlesex Hospital, London, UK, 1982-1983; residency, Pediatrics, Newark Beth Israel Medical Center, Newark, N.J., 1985-1988; fellowship, Pediatric Endocrinology, Metabolism & Nutrition, North Shore University Hospital-Cornell University Medical College, Manhasset, N.Y., 1988-1991.                

Certification(s): Pediatrics, Pediatric Endocrinology.

Honors: American Medical Association.

Research interests: Diabetes, obesity, insulin resistance, hyperlipidemia, hypoglycemia, insulin pump therapy, diabetic nephropathy and metabolic bone disease.

Representative publications:

  • Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial Effects of Continuous Subcutaneous Insulin Infusion (CSII and Flexible Multiple Daily Insulin (FMDI) Regimen Using Insulin Glargine in Type 1 Diabetes Mellitus. Pediatrics 2004; 114: e91-e95. URL: www.pediatrics.org/cgi/content/full/114/1/e91. 
  • Alemzadeh R, Fledelius C, Bodvarsdottir T, Sturis J. Attenuation of Hyperinsulinemia by NN414, a SUR1/Kir6.2 Selective K+ATP Channel Opener, Improves Glucose Tolerance and Lipid Profile in Obese Zucker Rats. Metabolism 53(4): 441-447, 2004. 
  • Alemzadeh R, Tushausn K. Modulation of Adipoinsular Axis in Prediabetic ZDF Rats by Diazoxide. Endocrinology 145: 5476-5484, 2004.   
  • Alemzadeh R, Palma-Sisto P, Holzum MK, Parton E. Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Dose of Insulin (MDI) Regimen Display Similar Patterns of Blood Glucose Excursions in Pediatric Type 1 Diabetes (DM). Diabetes Technology and Therapeutics 2005; 7 (4): 587-596.
  • Battaglia MR, Alemzadeh R, Katte H, Hall PL, Perlmuter LC. Brief Report: Disordered Eating and Psychosocial Factors in Female Adolescents with Type 1 Diabetes Mellitus. Journal of Pediatric Psychology 2005. doi:10.1093/jpepsy/jsj047
  • Alemzadeh R, Berhe T, Wyatt DT. Feasibility of Flexible Insulin Therapy with Glargine in Pre-School Children with Type 1 Diabetes Mellitus. Pediatrics 115(5): 1320-1324, 2005.  
  • Alemzadeh R, Lifshitz F. Childhood Obesity. Pediatric Endocrinology, 5th edition, Ed. Lifshits F, Marcel Dekker, Inc., New York, 2006.

  • Alemzadeh, R, Wyatt DT. Diabetes Mellitus. Nelson Text Book of Pediatrics, 18th edition, Eds. Behrman, Kliegman, Jensen, WB Saunders, Philadelphia, Pa., 2006.

Current grants:

  • Use of (Glycosylated Hemoglobin), Pediatric Growth Parameters, Maternal Prenatal Health History and Early Feeding Practices in Screening for Impaired Glucose Tolerance and Undiagnosed Type 2 Diabetes. Source: Children's Hospital and Health System Foundation.
  • Family Genetic Study in Type 1 Diabetes Mellitus. Source: NIH-supported GCRC grant.
  • Feasibility of Continuous Subcutaneous Insulin Therapy in Toddler/Preschool Children with Type 1 Diabetes Mellitus. Source: Medtronic/MiniMed and Novo Nordisk Pharmaceuticals.                        

Contact information: 8701 Watertown Plank Road, Milwaukee, WI, 53226. Phone: (414) 266-6750. Fax: (414) 266-6749. E-mail: ralemzad@mcw.edu.